Nature Medicine
3, 1074 - 1075 (1997)
doi:10.1038/nm1097-1074
A chemokine trap for HIV co-receptorsPaolo LussoUnit of Human Virology, Department of Biological and Technological, Research (DIBIT), San Raffaele Scientific Institute 20132 Milano, Italy A novel anti-HIV strategy uses modified chemokines (intrakines), trapped within the endoplasmic reticulum, to block expression of HIV co-receptors on the host cell surface (pages 1110−1116).
REFERENCES
- Berger, E.A. HIV entry and tropism: the chemokine receptor connection. AIDS 11 (Suppl. A), S3−S16 (1997). | PubMed | ISI |
- Lusso, P. & Gallo, R.C. Chemokines and HIV infection. Curr. Op. Infect. Dis. 10, 12−17 (1997). | ISI |
- Moore, J.P., Trkola, A. & Dragic, T. Co-receptor for HIV-1 entry. Curr Op. Immunol. 9, 450−468 (1997).
- Cohen, J. Exploiting the HIV-chemokine nexus. Science 275, 1261−1264 (1997). | Article | PubMed | ISI | ChemPort |
- Chen, J.-D. et al. Inactivation of HIV-1 chemokine co-receptor CXCR4 by a novel intrakine strategy. Nature Med. 3, 1110−1116 (1997). | Article | PubMed | ISI | ChemPort |
- Chen, S.-Y., Bagley, J. & Marasco, W.A. IntraCellular antibodies as a new class of therapeutic molecules for gene therapy. Hum. Gene Ther. 5, 595−601 (1994). | PubMed | ISI | ChemPort |
- Feng, Y., Broder, C.C., Kennedy, P.E. & Berger, E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872−877 (1996). | PubMed | ISI | ChemPort |
- Scarlatti, G. et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nature Med. in the press.
- Yang, A.-G. et al. Phenotypic knockout of chemokine receptor CCR5 by intrakines as a potential therapeutic approach for HIV-1 infection. Proc. Natl. Acad. Sci USA, in the press.
- Cocchi, F. et al. Identification of RANTES, MIP-1
 and MIP-1 as the major HIV-suppressive factors produced by CD8+ T Cells. Science 270, 1811−1815 (1995). | PubMed | ISI | ChemPort |
|
